FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and relates to a therapeutic agent for amyotrophic lateral sclerosis, comprising a growth hormone secretagogue receptor agonist or a pharmaceutically acceptable salt thereof as an active ingredient, for administration to an individual suffering from amyotrophic lateral sclerosis without severe dysphagia. Group of inventions also relates to a method for treating amyotrophic lateral sclerosis, comprising administering said therapeutic agent; relates to the use of a growth hormone secretagogue receptor agonist or a pharmaceutically acceptable salt thereof for treating amyotrophic lateral sclerosis.
EFFECT: group of inventions prolongs survival periods as a result of suppression of pathological progression of ALS.
24 cl, 9 ex, 17 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| STIMULATOR OF PANCREATIC BETA-CELL REGENERATION AND INSULIN PRODUCTION IN PANCREATIC BETA-CELLS | 2006 |
|
RU2403058C2 |
| THERAPEUTIC MEDICATION FOR ACCELERATED SKIN HEALING, WHICH CONTAINS AS ACTIVE INGREDIENT GRELIN AND ITS DERIVATIVES OR SUBSTANCE INFLUENCING GHS-RLa RECEPTOR | 2006 |
|
RU2420306C2 |
| PEPTIDE ANALOGUE COMPOUNDS OF GROWTH HORMONE SECRETION STIMULANTS AND PREPARATIONS CONTAINING SAID COMPOUNDS | 2007 |
|
RU2416618C2 |
| HUMAN GROWTH HORMONE SECRETION STIMULANTS | 2006 |
|
RU2416612C9 |
| ANALOGUES OF GHRELIN SUBSTITUTED AT N-END | 2007 |
|
RU2459831C2 |
| USE OF GHRELIN SPLICING VERSION FOR TREATING CACHEXIA AND/OR ANOREXIA, AND/OR ANOREXIA-CACHEXIA, AND/OR EATING DISORDER, AND/OR LIPODYSTROPHY, AND/OR MUSCLE ATROPHY, AND/OR APPETITE STIMULATION | 2007 |
|
RU2470940C2 |
| USE OF SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1N-BENZO[D]IMIDAZOL-2-AMINE AND THEIR SOLVATES FOR TREATMENT OF MOTOR NEURON DISEASES AND NEUROMUSCULAR DISEASES | 2021 |
|
RU2814327C1 |
| USE OF PEPTIDE THAT ENHANCES SECRETION OF SOMATOTROPIC HORMONE AS VACCINE ADJUVANT | 2017 |
|
RU2768134C2 |
| GHRELIN ANALOGUES | 2003 |
|
RU2373220C2 |
| TREATMENT METHOD FOR AMYOTROPHIC LATERAL SCLEROSIS | 2023 |
|
RU2804196C1 |
